Effects of HMG-CoA reductase inhibition on erythrocyte membrane cholesterol and acyl chain composition

Clinica Chimica Acta

Volumn 256, Issue 1, 1996, Pages 53-63

  Dwight, J F StJ ^b   Mendes Ribeiro, A C ^c   Hendrya, B M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c Laboratory of Physiology   (United Kingdom)

Author keywords

Acyl chains; Cholesterol; Erythrocyte; Fatty acids; HMG CoA reductase; Membrane; Simvastatin

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LINOLEIC ACID; PLACEBO; SIMVASTATIN;

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; ERYTHROCYTE FRAGILITY; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; LIPID COMPOSITION; MEMBRANE STRUCTURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0042813926     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(96)06412-1     Document Type: Article

References (29)

1. [1] The Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
2. [2] Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995;333:1301-1307.
3. [3] Nakahara K, Kuriyama M, Yoshidome H et al. Experimental simvastatin-induced myopathy in rabbits. J Neurol Sci 1992;113:114-117.
4. [4] Grundy SM. HMG-CoA Reductase inhibitors for treatment of hypercholesterolaemia. N Engl J Med 1989;319:24-33.
5. [5] Oliver MF. Doubts about preventing coronary heart disease. Br Med J 1992;304:393-394.
6. [6] Davey Smith G, Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs? Br Med J 1992;304:431-434.
7. [7] Bruckdorfer KR, Graham JM. The exchange of cholesterol and phospholipids between cell membranes and lipoproteins. In: Chapman D, ed. Biological Membranes. New York: Academic Press, 1976;3:103-152.
8. [8] Levy Y, Leibowitz R, Aviram, M, Brook, JG, Cogan, U. Reduction in plasma cholesterol by lovastatin normalises erythrocyte membrane fluidity in patients with severe hypercholesterolaemia. Br J Clin Pharmacol 1992;34:427-430.
9. [9] Lijnen P, Celis H, Fagard R, Staessen J, Amery A. Influence of cholesterol lowering on plasma membrane lipids and cationic transport mechanisms. J Hypertens 1994;12:59-64.
10. [10] van Doormaal JJ, Bos WJW, Muskiet FAJ, Doorenbos H. Simvastatin influences linoleic acid metabolism. Pharmaceut Weekblad Sci. 1989;11:134-135.
11. [11] Keech A, Collins R, MacMahon S et al. Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. Eur Heart J 1994;15:255-269.
12. [12] Rose HG, Ocklander M. Improved procedure for the extraction of lipids from human erythrocytes. J Lipid Res 1965;6:428-431.
13. [13] Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 1964;5:600-608.
14. [14] Yandrasitz JR, Berry G, Segal S. High-performance liquid chromatography of phospholipids with UV detection: optimization of separations on silica. J Chromatogr 1981;225:319-328.
15. [15] Peuchant E, Salles C, Vallot, C, Wone C, Jensen R. Increase of erythrocyte resistance to haemolysis and modification of membrane lipids induced by haemodialysis. Clin Chim Acta 1988;178:271-282.
16. [16] Lucio FJ, Hendry BM, Ellory JC. The effects of cholesterol depletion on the sodium pump in human red cells. Exp Physiol 1991;76:437-443.
17. [17] Farquhar JW, Ahrens EH. Effects of dietary fats on human erythrocyte fatty acid patterns. J Clin Invest 1963;42:675-685.
18. [18] Popp-Snijders C, Schouten JA, van Blitterswijk WJ, van der Veen EA. Changes in membrane lipid composition of human erythrocytes after dietary supplementation of (n-3) polyunsaturated fatty acids. Maintenance of membrane fluidity. Biochim Biophys Acta 1986;854:31-37.
19. [19] Glatz Jan FC, Soffers Ans EMF, Katan MB. Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr 1989;49:269-276.
20. [20] Hrboticky N, Tang L, Zimmer B, Lux I, Weber PC. Lovastatin increases arachidonic acid levels and stimulates thomboxane synthesis in human liver and monocytic cell lines. J Clin Invest 1994;93:195-203.
21. [21] Bredie SJ, de-Bruin TW, Demacker PN, Kastelein JJ, Stalenhoef AF. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidaemia and effects on apolipoprotein B containing lipoproteins, low-density lipoprotein subfraction profile and low-density lipoprotein oxidisability. Am J Cardiol 1995;75:348-353.
22. [22] Reed CF. Phospholipid exchange between plasma and erythrocytes in man and dog. J Clin Inv 1968;47:749-760.
23. [23] Rabini RA, Polenta M, Staffolani R et al. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes. Exp Mol Pathol 1993;59:51-57.
24. [24] Pogue DH, Moravec CS, Roppelt C et al. Effect of lovastatin on cholesterol content of cardiac and red blood cell membranes in normal and cardiomyopathic hamsters. J Pharmacol Exp Ther 1995;273:863-869.
25. [25] Feilding CJ. The origins and properties of free cholesterol potential gradients in plasma and their relation to atherogenesis. J Lipid Res 1984;25:1624-1628.
26. [26] Bagdade JD, Yee E, Wilson DE, Shafrir E. Hyperlipidemia in renal failure: studies of plasma lipoproteins, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat model. J Lab Clin Med 1978;91:176-186.
27. [27] Hui DY, Noel JG, Harmony JAK. Binding of plasma low density lipoproteins to erythrocytes. Biochim Biophys Acta 1981;664:513-526.
28. 3H]-cholesterol between lipid vesicles and rat arterial smooth muscle cells in vitro. Biochim Biophys Acta 1983;750:434-439.
29. 3H]-cholesterol from low density lipoprotein by cultured human fibroblasts. Biochim Biophys Acta 1982;711:281-289.